Try our beta test site
170 studies found for:    lupus | Open Studies
Show Display Options
Rank Status Study
21 Recruiting A Study of Baricitinib (LY3009104) in Participants With Systemic Lupus Erythematosus (SLE)
Condition: Systemic Lupus Erythematosus
Interventions: Drug: Baricitinib;   Drug: Placebo
22 Recruiting Safety and Efficacy of Two Doses of Anifrolumab Compared to Placebo in Adult Subjects With Active Proliferative Lupus Nephritis
Condition: Lupus Nephritis
Interventions: Biological: Anifrolumab;   Drug: Placebo
23 Recruiting A Phase 2a of RSLV-132 in Subjects With Systemic Lupus Erythematosus (SLE)
Condition: Systemic Lupus Erythematosus
Interventions: Drug: RSLV-132;   Drug: Placebo
24 Not yet recruiting A Study of the Safety and Efficacy of GDC-0853 in Participants With Moderate to Severe Active Systemic Lupus Erythematosus
Condition: Systemic Lupus Erythematosus
Interventions: Drug: GDC-0853 (high dose);   Drug: GDC-0853 (low dose);   Drug: Placebo
25 Recruiting Nelfinavir in Systemic Lupus Erythematosus
Condition: Systemic Lupus Erythematosus
Intervention: Drug: Nelfinavir
26 Recruiting RING - Rituximab for Lupus Nephritis With Remission as a Goal
Condition: Lupus Nephritis
Interventions: Drug: RTX infusions;   Other: Standard of Care
27 Recruiting Prevalence and Clinical Severity of Cutaneous Lupus Erythematosus
Condition: Cutaneous Lupus Erythematosus
Intervention:
28 Recruiting Efficacy and Safety of Anifrolumab Compared to Placebo in Adult Subjects With Active Systemic Lupus Erythematosus
Condition: Active Systemic Lupus Erythematosus
Interventions: Biological: Anifrolumab;   Drug: Placebo
29 Recruiting Dipyridamole Assessment for Flare Reduction in Systemic Lupus Erythematosus (SLE)
Condition: Systemic Lupus Erythematosus
Interventions: Drug: extended release dipyridamole 200mg/aspirin 25mg;   Drug: 81mg aspirin
30 Recruiting Efficacy and Safety of Two Doses of Anifrolumab Compared to Placebo in Adult Subjects With Active Systemic Lupus Erythematosus
Condition: Active Systemic Lupus Erythematosus
Interventions: Biological: Anifrolumab;   Drug: Placebo
31 Not yet recruiting Lupus Intervention for Fatigue Trial
Conditions: Fatigue;   Physical Activity;   Lupus Erythematosus, Systemic
Interventions: Behavioral: Experimental;   Other: Control
32 Recruiting Trial of Rituximab and Mycophenolate Mofetil Without Oral Steroids for Lupus Nephritis
Condition: Systemic Lupus Erythematosus, Lupus Nephritis
Interventions: Drug: Oral prednisolone;   Drug: Rituximab;   Drug: Mycophenolate mofetil;   Drug: Methyl prednisolone
33 Not yet recruiting Lupus and Observance
Condition: Systemic Lupus, Skin Lupus
Intervention: Biological: Hydroxychloroquine dosage
34 Recruiting Proof-of-Concept Study With BT063 in Subjects With Systemic Lupus Erythematosus
Condition: Systemic Lupus Erythematosus
Interventions: Biological: BT063;   Biological: Placebo
35 Recruiting Efficacy and Safety of Tacrolimus Versus Mycophenolate in Lupus Nephritis
Condition: Lupus Nephritis
Interventions: Drug: Tacrolimus;   Drug: Mycophenolate mofetil
36 Recruiting Autologous EBV-specific Cytotoxic T Cells for the Treatment of Systemic Lupus Erythematosus (SLE)
Condition: Serologically Active Adult Systemic Lupus Erythematosus
Intervention: Biological: Autologous EBV specific CTL infusion
37 Recruiting Walk With Ease Program For Patients With Systemic Lupus Erythematosus
Condition: Systemic Lupus Erythematosus
Intervention: Other: "Walk With Ease"
38 Recruiting Development of a Novel Glutamate Receptor Ligand for PET Scans in Neuropsychiatric Systemic Lupus Erythematosus
Condition: Systemic Lupus Erythematosus
Intervention:
39 Recruiting High Quality Evidence of Chinese Lupus Nephritis (HELP)
Condition: Lupus Nephritis
Intervention: Other: No Intervention
40 Not yet recruiting Aurinia Renal Response in Active Lupus With Orelvo (Voclosporin)
Condition: Lupus Nephritis
Interventions: Drug: Voclosporin;   Drug: Placebo Oral Capsule

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.